@gliapharm.com
We are taking the work of decades on the role of glial cells in brain function and health for the benefit of patients suffering challenging disorders.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
GliaPharm is a Swiss biotechnology company that specializes in developing advanced treatments for neurological and psychiatric disorders. Their unique therapeutic approach revolves around targeting glial cells, which are essential for maintaining the function and survival of neurons, and enhancing brain metabolism in pathological conditions. By focusing on glia-mediated pathways, GliaPharm aims to develop groundbreaking drugs that can provide neuroprotection and preserve cognitive functions.
Their research focuses on a range of conditions such as Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), depression, and the orphan neurometabolic disease GLUT1 deficiency syndrome. The company was founded in 2016 as a spinoff of the renowned laboratory of Prof. Pierre Magistretti at Ecole Polytechnique Fédérale de Lausanne.
Since then, GliaPharm has established its laboratory at the renowned Campus Biotech in Geneva. With their proprietary drug discovery platform, GliaX™, the company is actively developing a pipeline of innovative agents for neuroprotection and cognitive maintenance. They also collaborate extensively with academic and industrial partners to expand their research and development capabilities.
For the latest news and updates, visit GliaPharm's website
Company Type
Partnership
Company Size
2-10
Year Founded
2016
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online